Charles B Hall

Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.

K. Anastos, S. Gange, J. Palefsky, 2003, Journal of the National Cancer Institute.

Epidemiological evidence that common HPV types may be common because of their ability to evade immune surveillance: Results from the Women's Interagency HIV study

K. Anastos, J. Palefsky, P. Castle, 2020, International journal of cancer.

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.

K. Anastos, J. Palefsky, R. Burk, 2005, Journal of the National Cancer Institute.

Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.

K. Anastos, J. Palefsky, R. Burk, 2005, JAMA.

Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.

R. Burk, R. Bierman, L. Beardsley, 2002, The Journal of infectious diseases.

Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women.

K. Anastos, S. Gange, J. Palefsky, 2005, The Journal of general virology.